BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15215239)

  • 21. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.
    Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G
    Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
    Zhai P; Wakeham N; Loy JA; Zhang XC
    Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of omega-amino acids on plasminogen activation and fibrinolysis induced by staphylokinase.
    Levashov MY; Aisina RB; Gershkovich KB; Varfolomeyev SD
    Biochemistry (Mosc); 2007 Jul; 72(7):707-15. PubMed ID: 17680762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain.
    Terzyan S; Wakeham N; Zhai P; Rodgers K; Zhang XC
    Proteins; 2004 Aug; 56(2):277-84. PubMed ID: 15211511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The β-domain of streptokinase affects several functionalities, including specific/proteolytic activity kinetics.
    Rafipour M; Keramati M; Aslani MM; Arashkia A; Roohvand F
    FEBS Open Bio; 2019 Jul; 9(7):1259-1269. PubMed ID: 31087538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering streptokinase for generation of active site-labeled plasminogen analogs.
    Laha M; Panizzi P; Nahrendorf M; Bock PE
    Anal Biochem; 2011 Aug; 415(2):105-15. PubMed ID: 21570944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen.
    Edelberg JM; Gonzalez-Gronow M; Pizzo SV
    Biochemistry; 1989 Mar; 28(6):2370-4. PubMed ID: 2525048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides.
    Nihalani D; Kumar R; Rajagopal K; Sahni G
    Protein Sci; 1998 Mar; 7(3):637-48. PubMed ID: 9541396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of deletion of streptokinase residues 48-59 on plasminogen activation.
    Wakeham N; Terzyan S; Zhai P; Loy JA; Tang J; Zhang XC
    Protein Eng; 2002 Sep; 15(9):753-61. PubMed ID: 12456874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
    J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.
    Wang S; Reed GL; Hedstrom L
    Biochemistry; 1999 Apr; 38(16):5232-40. PubMed ID: 10213631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic and structural characterization of a two-domain streptokinase: dissection of domain functionality.
    Johnsen LB; Rasmussen LK; Petersen TE; Etzerodt M; Fedosov SN
    Biochemistry; 2000 May; 39(21):6440-8. PubMed ID: 10828958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.
    Wang S; Reed GL; Hedstrom L
    Eur J Biochem; 2000 Jul; 267(13):3994-4001. PubMed ID: 10866798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogen activators of plasminogen.
    Verhamme IM; Panizzi PR; Bock PE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S106-14. PubMed ID: 26149011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.
    Rajamohan G; Dikshit KL
    FEBS Lett; 2000 Jun; 474(2-3):151-8. PubMed ID: 10838076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
    Takada A; Takada Y; Sugawara Y
    Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of human plasminogen activation.
    Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
    Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
    Nihalani D; Raghava GP; Sahni G
    Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.